NextCure, Inc. (NXTC) Free cash flow 2018–2024
NextCure, Inc. (NXTC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$41.3MFY2024 · since FY2018: $4.9M → -$41.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$41.3M | +23.3% |
| FY2023 | -$53.8M | +3.9% |
| FY2022 | -$56.0M | +6.1% |
| FY2021 | -$59.6M | -14.5% |
| FY2020 | -$52.1M | -33.6% |
| FY2019 | -$39.0M | -891.1% |
| FY2018 | $4.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice